ArticleDigestive diseases and sciences2018
Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Rikke B Holmstrøm et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it